Continuous glucose monitoring in children with glycogen storage disease type I.

Abstract

Glycogen storage disease type I (GSD I) is characterized by impaired production of glucose from glycogenolysis and gluconeogenesis resulting in severe fasting hypoglycaemia. The aim of the present study was to examine the efficacy of a continuous subcutaneous glucose monitoring system (CGMS MiniMed), to determine the magnitude and significance of hypoglycaemia in GSD I and to evaluate the efficacy of its dietary treatment. Four children with GSD I were studied over a 72-h period. Results indicated that the values recorded with continuous subcutaneous glucose monitoring were highly correlated with paired blood glucose values measured by glucometer. Significant periods of asymptomatic hypoglycaemia were noted, especially during night-time. The study suggests that repeated continuous subcutaneous glucose monitoring may serve as a useful tool for the assessment of the long-term management of GSD I patients.

• Authors: E Hershkovitz, A Rachmel, H Ben-Zaken, M Phillip
• Journal: Journal of inherited metabolic disease (J Inherit Metab Dis) Vol. 24 Issue 8 Pg. 863-9 (Dec 2001) ISSN: 0141-8955 [Print] United States
• PMID: 11916320 (Publication Type: Case Reports, Clinical Trial, Comparative Study, Journal Article)

Chemical References

• Blood Glucose
• Glucose

Topics

• Adolescent
• Blood Glucose (metabolism)
• Child
• Child, Preschool
• Female
• Glucose (administration & dosage, metabolism)
• Glycogen Storage Disease Type I (blood, diet therapy, metabolism)
• Humans
• Hypoglycemia (diagnosis, diet therapy, metabolism)
• Male
• Monitoring, Physiologic (instrumentation, methods)